These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38243871)

  • 1. Mulberry Leaf Lipid Nanoparticles: a Naturally Targeted CRISPR/Cas9 Oral Delivery Platform for Alleviation of Colon Diseases.
    Ma L; Ma Y; Gao Q; Liu S; Zhu Z; Shi X; Dai F; Reis RL; Kundu SC; Cai K; Xiao B
    Small; 2024 Jun; 20(25):e2307247. PubMed ID: 38243871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetic MOF Nanoparticles Delivery of C-Dot Nanozyme and CRISPR/Cas9 System for Site-Specific Treatment of Ulcerative Colitis.
    Ma Y; Gao W; Zhang Y; Yang M; Yan X; Zhang Y; Li G; Liu C; Xu C; Zhang M
    ACS Appl Mater Interfaces; 2022 Feb; 14(5):6358-6369. PubMed ID: 35099925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components.
    Kazemian P; Yu SY; Thomson SB; Birkenshaw A; Leavitt BR; Ross CJD
    Mol Pharm; 2022 Jun; 19(6):1669-1686. PubMed ID: 35594500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo.
    Walther J; Porenta D; Wilbie D; Seinen C; Benne N; Yang Q; de Jong OG; Lei Z; Mastrobattista E
    Eur J Pharm Biopharm; 2024 Mar; 196():114207. PubMed ID: 38325664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In utero delivery of targeted ionizable lipid nanoparticles facilitates in vivo gene editing of hematopoietic stem cells.
    Palanki R; Riley JS; Bose SK; Luks V; Dave A; Kus N; White BM; Ricciardi AS; Swingle KL; Xue L; Sung D; Thatte AS; Safford HC; Chaluvadi VS; Carpenter M; Han EL; Maganti R; Hamilton AG; Mrksich K; Billingsley MB; Zoltick PW; Alameh MG; Weissman D; Mitchell MJ; Peranteau WH
    Proc Natl Acad Sci U S A; 2024 Aug; 121(32):e2400783121. PubMed ID: 39078677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan-modified lipid nanodrug delivery system for the targeted and responsive treatment of ulcerative colitis.
    Chen SQ; Song YQ; Wang C; Tao S; Yu FY; Lou HY; Hu FQ; Yuan H
    Carbohydr Polym; 2020 Feb; 230():115613. PubMed ID: 31887935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: Clinical applications.
    Masarwy R; Stotsky-Oterin L; Elisha A; Hazan-Halevy I; Peer D
    Adv Drug Deliv Rev; 2024 Aug; 211():115359. PubMed ID: 38857763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy.
    Zhang D; Wang G; Yu X; Wei T; Farbiak L; Johnson LT; Taylor AM; Xu J; Hong Y; Zhu H; Siegwart DJ
    Nat Nanotechnol; 2022 Jul; 17(7):777-787. PubMed ID: 35551240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finely tuned ionizable lipid nanoparticles for CRISPR/Cas9 ribonucleoprotein delivery and gene editing.
    Im SH; Jang M; Park JH; Chung HJ
    J Nanobiotechnology; 2024 Apr; 22(1):175. PubMed ID: 38609947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LNP-mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea.
    Mirjalili Mohanna SZ; Djaksigulova D; Hill AM; Wagner PK; Simpson EM; Leavitt BR
    J Control Release; 2022 Oct; 350():401-413. PubMed ID: 36029893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy.
    Han JP; Kim M; Choi BS; Lee JH; Lee GS; Jeong M; Lee Y; Kim EA; Oh HK; Go N; Lee H; Lee KJ; Kim UG; Lee JY; Kim S; Chang J; Lee H; Song DW; Yeom SC
    Sci Adv; 2022 Jan; 8(3):eabj6901. PubMed ID: 35061543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.
    Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D
    Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing.
    Finn JD; Smith AR; Patel MC; Shaw L; Youniss MR; van Heteren J; Dirstine T; Ciullo C; Lescarbeau R; Seitzer J; Shah RR; Shah A; Ling D; Growe J; Pink M; Rohde E; Wood KM; Salomon WE; Harrington WF; Dombrowski C; Strapps WR; Chang Y; Morrissey DV
    Cell Rep; 2018 Feb; 22(9):2227-2235. PubMed ID: 29490262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy.
    Rosenblum D; Gutkin A; Kedmi R; Ramishetti S; Veiga N; Jacobi AM; Schubert MS; Friedmann-Morvinski D; Cohen ZR; Behlke MA; Lieberman J; Peer D
    Sci Adv; 2020 Nov; 6(47):. PubMed ID: 33208369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural lipid nanoparticles extracted from Morus nigra L. leaves for targeted treatment of hepatocellular carcinoma via the oral route.
    Gao Q; Chen N; Li B; Zu M; Ma Y; Xu H; Zhu Z; Reis RL; Kundu SC; Xiao B
    J Nanobiotechnology; 2024 Jan; 22(1):4. PubMed ID: 38169394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized microfluidic formulation and organic excipients for improved lipid nanoparticle mediated genome editing.
    Palanki R; Han EL; Murray AM; Maganti R; Tang S; Swingle KL; Kim D; Yamagata H; Safford HC; Mrksich K; Peranteau WH; Mitchell MJ
    Lab Chip; 2024 Aug; 24(16):3790-3801. PubMed ID: 39037068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-triggered surface charge-reversal nanoparticles alleviate experimental murine colitis via selective accumulation in inflamed colon regions.
    Naeem M; Oshi MA; Kim J; Lee J; Cao J; Nurhasni H; Im E; Jung Y; Yoo JW
    Nanomedicine; 2018 Apr; 14(3):823-834. PubMed ID: 29353017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Size-controlled lipid nanoparticle production using turbulent mixing to enhance oral DNA delivery.
    He Z; Hu Y; Nie T; Tang H; Zhu J; Chen K; Liu L; Leong KW; Chen Y; Mao HQ
    Acta Biomater; 2018 Nov; 81():195-207. PubMed ID: 30267888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular Delivery of mRNA for Cell-Selective CRISPR/Cas9 Genome Editing using Lipid Nanoparticles.
    Ma T; Chen X; Wang M
    Chembiochem; 2023 May; 24(9):e202200801. PubMed ID: 36780174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lycium barbarum lipid-based edible nanoparticles protect against experimental colitis.
    Zu M; Song H; Zhang J; Chen Q; Deng S; Canup BSB; Yuan Y; Xiao B
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110747. PubMed ID: 31924469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.